Research Progress Related to Scleroderma
NIAMS is funding and conducting research to find better ways to treat symptoms, prevent organ damage, and improve the quality of life for people with scleroderma.
Here are some other areas of ongoing research:
- Exploring the complex immune system, trying to determine why the body creates antibodies against its own tissues. Identifying where and when the antibodies are created and how they function could lead researchers to find targets for new therapies.
- Unraveling the genetic factors that predispose a person to getting scleroderma and scleroderma-associated lung fibrosis.
- Understanding why scleroderma can affect African Americans more severely.
- Evaluating how immunosuppressant and other medications can be used to help manage the symptoms and complications of scleroderma, particularly pulmonary complications.
- Exploring the many factors that lead to fibrosis to see if their development can be blocked.
- Determining how substances known as cytokines contribute to the disease process.
For more info
Centers for Disease Control and Prevention, National Center for Health Statistics
網站 cdc.gov/nchs (en inglés)
NHGRI Genetic and Rare Diseases Information Center
網站 https://www.genome.gov/Health (en inglés)
Genetics Home Reference
網站 https://medlineplus.gov/genetics/ (en inglés)
American College of Rheumatology
網站 rheumatology.org (en inglés)
National Scleroderma Foundation
網站 scleroderma.org (en inglés)
Scleroderma Research Foundation
網站 srfcure.org (en inglés)
如需您的語言版本或其他語言版本資源的詳情，請前往我們以下的網頁或聯繫NIAMS資訊中心，網址是[email protected]。